67-6

49/93

D, Sato J, Watada H. The Effect of Linagliptin versus Metformin Treatment Related Qualiy of Life in Patients with Type 2 Diabetes Mellitus. Diabes Ther. 2019; 10: 119-134. 11) Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suga-nami H, Ishibashi S: The Efficacy and Safety of Pemafibrate in Patients with Type 2 Diabetes and Elevated Triglyceride levels: 52-Week Data From The PROVIDE Study. Diabetes Obes Metab. 2019; 21: 1737-1744. 12) Yazawa R, Nishida Y, Aoyama S, Tanida I, Miyatsuka T, Suzuki L, Himuro M, Haruna H, Takubo N, Shimizu T, Watada H. Establish-ment of a system for screening autophagic flux regulators using a modified fluorescent reporter and CRISPR/Cas9. Biochem Biophys Res Commun. 2019; 516: 686-692. 13) Satoh H, Ohira T, Nagai M, Hosoya M, Sakai A, Yasumura S, Ohtsuru A, Kawasaki Y, Suzuki H, Takahashi A, Sugiura Y, Shishido H, Hayashi Y, Takahashi H, Kobashi G, Ozasa K, Hashimoto S, Ohto H, Abe M, Kamiya K, Fukushima Health Management Survey G: Evacuation is a risk factor for diabetes devel-opment among evacuees of the Great East Japan earthquake: A 4-year follow-up of the Fukushima Health Management Survey. Diabetes Metab. 2019; 45: 312-315. 14) Kudo A, Asahi K, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Watanabe T, Shimabukuro M: Fast eating is a strong risk factor for new- onset diabetes among the Japanese general population. Sci Rep. 2019; 9: 8210. 15) Kadowaki S, Tamura Y, Someya Y, Takeno K, Kaga H, Sugimoto D, Kakehi S, Funayama T, Furukawa Y, Suzuki R, Nishitani-Yo-koyama M, Shimada K, Daida H, Aoki S, Kanazawa A, Kawamori R, Watada H: Fatty Liver Has Stronger Association With Insulin Resistance Than Visceral Fat Accumulation in Nonobese Japanese Men. J Endocr Soc. 2019; 3: 1409-1416. 16) Watada H, Shiramoto M, Irie S, Terauchi Y, Yamada Y, Shiosakai K, Myobatake Y, Taguchi T: G protein-coupled receptor 119 agonist 17) Kaga H, Tamura Y, Takeno K, Kakehi S, Someya Y, Funayama T, Furukawa Y, Suzuki R, Sugimoto D, Kadowaki S, Nishitani-Yo-koyama M, Shimada K, Daida H, Aoki S, Giacca A, Kanazawa A, Kawamori R, Watada H: Higher C-Peptide Level During Glucose Clamp Is Associated With Muscle Insulin Resistance in Nonobese Japanese Men. J Endocr Soc. 2019; 3: 1847-1857. 18) Zhou F L, Watada H, Tajima Y, Berthelot M, Kang D, Esnault C, Shuto Y, Maegawa H, Koya D: Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium-glucose co-transporter-2 inhibitors with those receiving dipeptidyl peptidase-4 inhibitors, using a supervised machine-learning algorithm (PROFILE study): A retrospective analysis of a Japanese commer-cial medical database. Diabetes Obes Metab. 2019; 21: 1925-1934. 19) Iso T, Takahashi K, Yazaki K, Ifuku M, Nii M, Fukae T, Yazawa R, Ishikawa A, Haruna H, Takubo N, Kurita M, Ikeda F, Watada H, Shimizu T: In-Depth Insight Into the Mecha-nisms of Cardiac Dysfunction in Patients With Type 1 Diabetes Mellitus Using Layer-Spe-cific Strain Analysis. Circ J. 2019; 83: 1330-1337. 20) Hirai H, Asahi K, Yamaguchi S, Mori H, Satoh H, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Shibagaki Y, Kasahara M, Wata-nabe T, Shimabukuro M: New risk prediction model of coronary heart disease in partici-pants with and without diabetes: Assess-ments of the Framingham risk and Suita scores in 3-year longitudinal database in a Japanese population. Sci Rep. 2019; 9: 2813. 21) Watada H, Shiramoto M, Ueda S, Tang W, Asano M, Thoren F, Kim H, Yajima T, Boulton D W, Araki E: Pharmacokinetics and pharmacodynamics of dapagliflozin in combi-nation with insulin in Japanese patients with type 1 diabetes. Diabetes Obes Metab, 2019; 21: 876-882.DS-8500a effects on pancreatic beta-cells in Japanese type 2 diabetes mellitus patients. J Diabetes Investig. 2019; 10: 84-93.557